carnitine has been researched along with Atrophy in 15 studies
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
Excerpt | Relevance | Reference |
---|---|---|
"Therefore, the overlapping syndrome of chronic progressive external ophthalmoplegia in the MELAS syndrome is considered in this case." | 5.29 | CPEO and carnitine deficiency overlapping in MELAS syndrome. ( Chen, HL; Chuang, YH; Hsu, CC; Huang, HL; Jong, HJ; Lee, HC; Pang, CY; Shen, YY; Tsai, JL; Wei, YH, 1995) |
" In addition to the typical findings of Norman-Roberts syndrome, case 1 had atrial septal defect, corpus callosum agenesis, intracranial widespread calcification and case 2 had bilateral macular cherry-red spot, persistent foramen ovale, increased blood level of C6 hexanoylcarnitine, cavum septum pellucidum vergae anomaly and cerebellar atrophy." | 3.72 | Report of two Turkish infants with Norman-Roberts syndrome. ( Caksen, H; Cinal, A; Fryns, JP; Kirimi, E; Odabaş, D; Tuncer, O; Unal, O; Uner, A, 2004) |
"These data on disease progression will be useful in future studies using the canine model for therapeutic intervention studies." | 1.72 | Characterization of neurological disease progression in a canine model of CLN5 neuronal ceroid lipofuscinosis. ( Coates, JR; Jensen, CA; Katz, ML; Kick, GR; Meiman, EJ, 2022) |
"Neurodevelopmental delay and encephalopathy are complications of both HIV and GA1." | 1.48 | Favourable outcome in a child with symptomatic diagnosis of Glutaric aciduria type 1 despite vertical HIV infection and minor head trauma. ( Ackermann, C; Cotton, MF; Dobbels, EFM; Laughton, B; Springer, PE; Thomas, A, 2018) |
"Therefore, the overlapping syndrome of chronic progressive external ophthalmoplegia in the MELAS syndrome is considered in this case." | 1.29 | CPEO and carnitine deficiency overlapping in MELAS syndrome. ( Chen, HL; Chuang, YH; Hsu, CC; Huang, HL; Jong, HJ; Lee, HC; Pang, CY; Shen, YY; Tsai, JL; Wei, YH, 1995) |
"Carnitine levels were found to be reduced in all patients at diagnosis." | 1.29 | Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency. ( Athanassopoulos, S; Burlina, AB; Christensen, E; de Klerk, JB; Duran, M; Hoffmann, GF; Lehnert, W; Leonard, JV; Monavari, AA; Müller, E; Muntau, AC; Naughten, ER; Plecko-Starting, B; Superti-Furga, A; Zschocke, J, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (13.33) | 18.7374 |
1990's | 2 (13.33) | 18.2507 |
2000's | 7 (46.67) | 29.6817 |
2010's | 3 (20.00) | 24.3611 |
2020's | 1 (6.67) | 2.80 |
Authors | Studies |
---|---|
Meiman, EJ | 1 |
Kick, GR | 1 |
Jensen, CA | 1 |
Coates, JR | 1 |
Katz, ML | 1 |
Thomas, A | 1 |
Dobbels, EFM | 1 |
Springer, PE | 1 |
Ackermann, C | 1 |
Cotton, MF | 1 |
Laughton, B | 1 |
Mahfoud, A | 1 |
Domínguez, CL | 1 |
Rashed, M | 1 |
Durán, M | 2 |
Rodríguez, T | 1 |
Rodríguez, D | 1 |
Landa, V | 1 |
Schiff, M | 1 |
Bénit, P | 1 |
El-Khoury, R | 1 |
Schlemmer, D | 1 |
Benoist, JF | 1 |
Rustin, P | 1 |
Sonne, S | 1 |
Shekhawat, PS | 2 |
Matern, D | 2 |
Ganapathy, V | 2 |
Ignatowicz, L | 1 |
Kölker, S | 2 |
Hoffmann, GF | 3 |
Schor, DS | 1 |
Feyh, P | 1 |
Wagner, L | 1 |
Jeffrey, I | 1 |
Pourfarzam, M | 1 |
Okun, JG | 1 |
Zschocke, J | 3 |
Baric, I | 1 |
Bain, MD | 1 |
Jakobs, C | 1 |
Chalmers, RA | 1 |
Caksen, H | 1 |
Tuncer, O | 1 |
Kirimi, E | 1 |
Fryns, JP | 1 |
Uner, A | 1 |
Unal, O | 1 |
Cinal, A | 1 |
Odabaş, D | 1 |
Külkens, S | 1 |
Harting, I | 1 |
Sauer, S | 1 |
Gruber, S | 1 |
Bodamer, OA | 1 |
Oglesbee, D | 1 |
Freedenberg, D | 1 |
Kramer, KA | 1 |
Anderson, BD | 1 |
Hahn, SH | 1 |
Spasov, AA | 1 |
Iezhitsa, IN | 1 |
Pisarev, VB | 1 |
Snigur, GL | 1 |
Kravchenko, MS | 1 |
Srinivas, SR | 1 |
Bennett, MJ | 1 |
Boriack, R | 1 |
George, V | 1 |
Xu, H | 1 |
Prasad, PD | 1 |
Roon, P | 1 |
Hsu, CC | 1 |
Chuang, YH | 1 |
Tsai, JL | 1 |
Jong, HJ | 1 |
Shen, YY | 1 |
Huang, HL | 1 |
Chen, HL | 1 |
Lee, HC | 1 |
Pang, CY | 1 |
Wei, YH | 1 |
Athanassopoulos, S | 1 |
Burlina, AB | 1 |
de Klerk, JB | 1 |
Lehnert, W | 1 |
Leonard, JV | 1 |
Monavari, AA | 1 |
Müller, E | 1 |
Muntau, AC | 1 |
Naughten, ER | 1 |
Plecko-Starting, B | 1 |
Superti-Furga, A | 1 |
Christensen, E | 1 |
Medvedev, DI | 1 |
Babichenko, II | 1 |
Kravtsova, AI | 1 |
Eremina, IZ | 1 |
Markesbery, WR | 1 |
McQuillen, MP | 1 |
Procopis, PG | 1 |
Harrison, AR | 1 |
Engel, AG | 1 |
15 other studies available for carnitine and Atrophy
Article | Year |
---|---|
Characterization of neurological disease progression in a canine model of CLN5 neuronal ceroid lipofuscinosis.
Topics: Animals; Atrophy; Carnitine; Disease Progression; Dogs; Homozygote; Nervous System Diseases; Neurona | 2022 |
Favourable outcome in a child with symptomatic diagnosis of Glutaric aciduria type 1 despite vertical HIV infection and minor head trauma.
Topics: Amino Acid Metabolism, Inborn Errors; Atrophy; Brain; Brain Diseases; Brain Diseases, Metabolic; Car | 2018 |
[D-2-hydroxyglutaric aciduria. Report of two cases].
Topics: Anticonvulsants; Atrophy; Brain; Brain Diseases, Metabolic, Inborn; Carnitine; Child, Preschool; Con | 2009 |
Mouse studies to shape clinical trials for mitochondrial diseases: high fat diet in Harlequin mice.
Topics: Animals; Atrophy; Carnitine; Cattle; Cell Death; Cell Respiration; Cerebellum; Clinical Trials as To | 2011 |
Carnitine deficiency in OCTN2-/- newborn mice leads to a severe gut and immune phenotype with widespread atrophy, apoptosis and a pro-inflammatory response.
Topics: Animals; Apoptosis; Atrophy; Bone Morphogenetic Proteins; Carnitine; Cytokines; Down-Regulation; Ent | 2012 |
Glutaryl-CoA dehydrogenase deficiency: region-specific analysis of organic acids and acylcarnitines in post mortem brain predicts vulnerability of the putamen.
Topics: Acidosis; Acute Disease; Adolescent; Anticonvulsants; Atrophy; Brain; Carnitine; DNA Mutational Anal | 2003 |
Report of two Turkish infants with Norman-Roberts syndrome.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Atrophy; Brain; Carnitine; Cell Movement; Cerebellum | 2004 |
Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency.
Topics: Age of Onset; Aged; Atrophy; Brain Diseases, Metabolic, Inborn; Carnitine; Cerebral Cortex; Cognitio | 2005 |
Normal muscle respiratory chain enzymes can complicate mitochondrial disease diagnosis.
Topics: Acidosis, Lactic; Atrophy; Biopsy; Blotting, Western; Carnitine; Central Nervous System Cysts; Cereb | 2006 |
[Changes in myocardium, skeletal muscle and liver of rats fed carnitine-deficient diet and treated with carnitine optical isomers].
Topics: Animals; Atrophy; Carnitine; Diet; Fatty Liver; Liver; Male; Muscle, Skeletal; Myocardium; Rats; Ste | 2006 |
Spontaneous development of intestinal and colonic atrophy and inflammation in the carnitine-deficient jvs (OCTN2(-/-)) mice.
Topics: Amino Acid Transport Systems; Animals; Atrophy; Carnitine; Colon; Crohn Disease; Disease Models, Ani | 2007 |
CPEO and carnitine deficiency overlapping in MELAS syndrome.
Topics: Adult; Atrophy; Biopsy; Brain; Carnitine; Cerebral Cortex; DNA, Mitochondrial; Female; Humans; MELAS | 1995 |
Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency.
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Atrophy; Brain; Brain Diseases, Metabolic; Carniti | 1996 |
[Ultrastructural characteristics of the cerebellar cortex in the postnatal development of animals with protein-calorie malnutrition and in subsequent rehabilitation].
Topics: Age Factors; Animals; Atrophy; Carnitine; Caseins; Cerebellar Cortex; Dietary Proteins; Hypertrophy; | 1989 |
Muscle carnitine deficiency. Association with lipid myopathy, vacuolar neuropathy, and vacuolated leukocytes.
Topics: Atrophy; Biological Transport; Carnitine; Electromyography; Female; Humans; Leukocytes; Lipid Metabo | 1974 |